A higher percentage of GC patients with poorly differentiated disease were having elevated TP53 mRNA expression compared to GC patients with well differentiated disease (34.4 vs. 69.2%; OR = 4.3; p = 0.001). The gene discussed is TP53; the disease is gastric cancer.